Gregory A Abel

Gregory A Abel

UNVERIFIED PROFILE

Are you Gregory A Abel?   Register this Author

Register author
Gregory A Abel

Gregory A Abel

Publications by authors named "Gregory A Abel"

Are you Gregory A Abel?   Register this Author

96Publications

1591Reads

31Profile Views

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization.

Cancer 2019 Oct 8. Epub 2019 Oct 8.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32549DOI Listing
October 2019

Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction.

Breast J 2019 Sep 8. Epub 2019 Sep 8.

Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13592DOI Listing
September 2019

Practical allocation system for the distribution of specialised care during cellular therapy access scarcity.

J Med Ethics 2019 Aug 19;45(8):532-537. Epub 2019 Jun 19.

Department of Medicine, The MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/medethics-2018-105339DOI Listing
August 2019

How Do Blood Cancer Doctors Discuss Prognosis? Findings from a National Survey of Hematologic Oncologists.

J Palliat Med 2019 Jun 23;22(6):677-684. Epub 2019 Mar 23.

1 Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/jpm.2018.0441
Publisher Site
http://dx.doi.org/10.1089/jpm.2018.0441DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533786PMC
June 2019

Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.

J Geriatr Oncol 2019 May 22;10(3):486-489. Epub 2018 Nov 22.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S18794068183034
Publisher Site
http://dx.doi.org/10.1016/j.jgo.2018.10.010DOI Listing
May 2019

Function, Survival, and Care Utilization Among Older Adults With Hematologic Malignancies.

J Am Geriatr Soc 2019 May 4;67(5):889-897. Epub 2019 Apr 4.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgs.15835DOI Listing
May 2019

Pentito.

Authors:
Gregory A Abel

JAMA Oncol 2019 Apr;5(4):580

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.6869DOI Listing
April 2019

The Best Medicine.

Authors:
Gregory A Abel

JAMA Oncol 2019 Mar;5(3):350

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.6689DOI Listing
March 2019

Patients as experts: characterizing the most relevant patient-reported outcomes after hematopoietic cell transplantation.

Bone Marrow Transplant 2019 Mar 27. Epub 2019 Mar 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0518-0DOI Listing
March 2019

Perceptions of Oncologists About Sharing Clinic Notes with Patients.

Oncologist 2019 Jan 25;24(1):e46-e48. Epub 2018 Sep 25.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324628PMC
January 2019

What is the Role of the Arts in Medical Education and Patient Care? A Survey-based Qualitative Study.

J Med Humanit 2018 Dec;39(4):431-445

Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10912-018-9530-4DOI Listing
December 2018

Cognitive Impairment Among Older Patients With Hematologic Cancers-Reply.

JAMA Oncol 2018 12;4(12):1784

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jam
Publisher Site
http://dx.doi.org/10.1001/jamaoncol.2018.4654DOI Listing
December 2018

Impact of lenalidomide use among non-transfusion dependent patients with myelodysplastic syndromes.

Am J Hematol 2018 09 28;93(9):1119-1126. Epub 2018 Aug 28.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25166DOI Listing
September 2018

Meaningful changes in end-of-life care among patients with myeloma.

Haematologica 2018 08 10;103(8):1380-1389. Epub 2018 May 10.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2018.187609DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068022PMC
August 2018

Management of older adults with myelodysplastic syndromes (MDS).

J Geriatr Oncol 2018 07 29;9(4):302-307. Epub 2017 Dec 29.

Dana-Farber Cancer Institute, 450 Brookline Avenue, Dana 2056, Boston, MA 02215, USA; Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2017.12.002DOI Listing
July 2018

Cancer drug shortages: Awareness and perspectives from a representative sample of the US population.

Cancer 2018 05 8;124(10):2205-2211. Epub 2018 Apr 8.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31246DOI Listing
May 2018

What Does a Cancer Diagnosis Mean? Public Expectations in a Shifting Therapeutic Environment.

J Oncol Pract 2018 03 30;14(3):139-140. Epub 2018 Jan 30.

Dana-Farber Cancer Institute; Brigham and Women's Hospital, Boston, MA; and City of Hope, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.17.00009DOI Listing
March 2018

Financial Hardship after Hematopoietic Cell Transplantation: Lack of Impact on Survival.

Cancer Epidemiol Biomarkers Prev 2018 03 13;27(3):345-347. Epub 2018 Feb 13.

Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-17-1040DOI Listing
March 2018

Frailty and the management of hematologic malignancies.

Blood 2018 02 15;131(5):515-524. Epub 2017 Nov 15.

Section on Hematology and Oncology, Department of Internal Medicine, Wake Forest University Health Sciences, Winston-Salem, NC.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2017-09
Publisher Site
http://dx.doi.org/10.1182/blood-2017-09-746420DOI Listing
February 2018

Why are patients with blood cancers more likely to die without hospice?

Cancer 2017 Sep 22;123(17):3377-3384. Epub 2017 May 22.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568951PMC
September 2017

Self-reported sleep disturbance and survival in myelodysplastic syndromes.

Br J Haematol 2017 05 8;177(4):562-566. Epub 2017 Mar 8.

Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14573DOI Listing
May 2017

Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States.

Leuk Lymphoma 2017 04 25;58(4):982-985. Epub 2016 Aug 25.

b Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center , Yale University , New Haven , CT , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2016.1214954DOI Listing
April 2017

Low-molecular weight heparin versus vitamin K antagonists for the treatment of cancer-associated thrombosis: A cost-effectiveness analysis.

Thromb Res 2017 Feb 22;150:53-58. Epub 2016 Dec 22.

Hematology Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, United States; Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.thromres.2016.12.017DOI Listing
February 2017

Integrating Frailty, Comorbidity, and Quality of Life in the Management of Myelodysplastic Syndromes.

Am Soc Clin Oncol Educ Book 2016 ;35:e337-44

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA; Department of Medical Oncology/Hematology, Odette Cancer and Sunnybrook Health Sciences Center, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158639DOI Listing
January 2017

Assessing Quality of Care for the Myelodysplastic Syndromes.

Curr Hematol Malig Rep 2016 12;11(6):402-407

Division of Population Sciences and Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-016-0343-0DOI Listing
December 2016

Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.

Br J Haematol 2016 Dec 21;175(5):829-840. Epub 2016 Sep 21.

Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14305DOI Listing
December 2016

Direct-to-Consumer Drug Advertising in Oncology Is Not Beneficial to Patients or Public Health.

JAMA Oncol 2016 Nov;2(11):1397-1398

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2463DOI Listing
November 2016

Small Step for Geriatric Oncology That Could Have Been a Giant Leap.

J Clin Oncol 2016 11 31;34(33):4048-4049. Epub 2016 Oct 31.

Ryan D. Nipp, Massachusetts General Hospital Cancer Center and Harvard Medical School; Boston, MA; and Gregory A. Abel, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.0446DOI Listing
November 2016

High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.

J Natl Compr Canc Netw 2016 10;14(10):1274-1281

From Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Biostatistics and Data Coordinating Center, City of Hope National Medical Center, Duarte, California; Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, Texas; Hematology and Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan; Departments of Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York; Fox Chase Cancer Center, Philadelphia, Pennsylvania; Medicine/Lymphoma, Memorial Sloan Kettering Cancer Center, New York, New York; and James P. Wilmot Cancer Center, University of Rochester, Rochester, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531178PMC
http://dx.doi.org/10.6004/jnccn.2016.0136DOI Listing
October 2016

Barriers to Quality End-of-Life Care for Patients With Blood Cancers.

J Clin Oncol 2016 09 11;34(26):3126-32. Epub 2016 Jul 11.

Oreofe O. Odejide, Angel M. Cronin, Nolan B. Condron, Sean A. Fletcher, James A. Tulsky, Gregory A. Abel, Dana-Farber Cancer Institute; James A. Tulsky, Brigham and Women's Hospital, Boston, MA; and Craig C. Earle, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.8177DOI Listing
September 2016

Relationship between physician and patient assessment of performance status and survival in a large cohort of patients with haematologic malignancies.

Br J Cancer 2016 09 23;115(7):858-61. Epub 2016 Aug 23.

Department of Medicine, Division of Aging, Brigham and Women's Hospital, 1620 Tremont Street, Boston, MA 02120, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046210PMC
September 2016

Novel Data Sharing Between a Comprehensive Cancer Center and a Private Payer to Better Understand Care at the End of Life.

J Pain Symptom Manage 2016 08 24;52(2):161-9. Epub 2016 Mar 24.

Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2016.02.004DOI Listing
August 2016

Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant 2016 08 13;22(8):1504-1510. Epub 2016 May 13.

Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949125PMC
August 2016

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes.

Br J Haematol 2016 06 23;173(5):713-21. Epub 2016 Feb 23.

Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13987DOI Listing
June 2016

Potentially avoidable hospital admissions in older patients with acute myeloid leukaemia in the USA: a retrospective analysis.

Lancet Haematol 2016 Jun 18;3(6):e276-83. Epub 2016 May 18.

Bone Marrow Transplant Program, Department of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(16)30024-2DOI Listing
June 2016

Timeliness of End-of-Life Discussions for Blood Cancers: A National Survey of Hematologic Oncologists.

JAMA Intern Med 2016 Feb;176(2):263-5

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts5Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2015.6599DOI Listing
February 2016

Hospice Use Among Patients With Lymphoma: Impact of Disease Aggressiveness and Curability.

J Natl Cancer Inst 2016 Jan 5;108(1). Epub 2015 Oct 5.

Division of Population Sciences (OOO, AMC, GAA), Center for Lymphoma (OOO, ASL), and Center for Leukemia (GAA), Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Ontario Institute for Cancer Research, Toronto, Canada (CCE).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv280DOI Listing
January 2016

Accessibility and Quality of Online Cancer-Related Clinical Trial Information for Naïve Searchers.

Cancer Epidemiol Biomarkers Prev 2015 Oct 11;24(10):1629-31. Epub 2015 Aug 11.

Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Division of Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0274DOI Listing
October 2015

Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adults.

J Geriatr Oncol 2015 Jul 11;6(4):288-98. Epub 2015 Jun 11.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Geriatric Research Education and Clinical Center, VA Boston Medical Center, Boston, MA, United States; Division of Aging, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2015.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860010PMC
July 2015

Financial hardship and the intensity of medical care received near death.

Psychooncology 2015 May 23;24(5):572-8. Epub 2014 Jul 23.

Dana-Farber Cancer Institute, Boston, MA, USA; Harvard School of Public Health, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.3624DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305037PMC
May 2015

Does surveillance imaging after treatment for diffuse large B-cell lymphoma really work?

Authors:
Gregory A Abel

J Clin Oncol 2015 May 30;33(13):1427-9. Epub 2015 Mar 30.

Dana-Farber Cancer Institute, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.1120DOI Listing
May 2015

Limited stage diffuse large B-cell lymphoma: comparative effectiveness of treatment strategies in a large cohort of elderly patients.

Leuk Lymphoma 2015 Mar 6;56(3):716-24. Epub 2014 Aug 6.

Division of Population Sciences, Dana-Farber Cancer Institute , Boston, MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.930853DOI Listing
March 2015

Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS).

Leuk Res 2014 Dec 30;38(12):1420-4. Epub 2014 Sep 30.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Leukemia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2014.09.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314368PMC
December 2014

End-of-life care for blood cancers: a series of focus groups with hematologic oncologists.

J Oncol Pract 2014 Nov 7;10(6):e396-403. Epub 2014 Oct 7.

Dana-Farber Cancer Institute and University of Massachusetts Boston, Boston, MA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2014.001537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706135PMC
November 2014

Public advertising by cancer centers: are more data needed?

Authors:
Gregory A Abel

Ann Intern Med 2014 Jun;160(12):870-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M14-1081DOI Listing
June 2014

Reply to quality control of bone marrow aspirates: additional steps toward a safer and more efficient procedure.

Cancer 2014 May 30;120(9):1442. Epub 2014 Jan 30.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28603DOI Listing
May 2014

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia.

J Clin Oncol 2014 Feb 23;32(4):306-11. Epub 2013 Dec 23.

Stacie B. Dusetzina, School of Medicine and Lineberger Comprehensive Cancer Center and Cecil G. Sheps Center for Health Services Research; Stacie B. Dusetzina and Aaron N. Winn, Gillings School of Global Public Health; University of North Carolina at Chapel Hill, Chapel Hill, NC; Gregory A. Abel, Dana-Farber Cancer Institute; Haiden A. Huskamp and Nancy L. Keating, Harvard Medical School; and Nancy L. Keating, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.52.9123DOI Listing
February 2014

A novel community-based delivery model to combat cancer disparities.

Healthc (Amst) 2013 Dec 10;1(3-4):123-9. Epub 2013 Dec 10.

Dana-Farber Cancer Institute, 450 Brookline Ave., DA 1120, Boston, MA 02115, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hjdsi.2013.09.004DOI Listing
December 2013

Improving the quality of bone marrow assessment: Impact of operator techniques and use of a specimen preparation checklist.

Cancer 2013 Oct 6;119(19):3472-8. Epub 2013 Aug 6.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28249DOI Listing
October 2013

Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions.

Cancer 2013 Mar 6;119(5):1065-72. Epub 2012 Nov 6.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27814DOI Listing
March 2013

Optimal positioning of hematopoietic stem cell transplantation for older patients with myelodysplastic syndromes.

Curr Opin Hematol 2013 Mar;20(2):150-6

Division of Hematologic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32835d8e8eDOI Listing
March 2013

Comparative rates of adverse events with different formulations of intravenous iron.

Am J Hematol 2012 Nov 11;87(11):E123-4. Epub 2012 Sep 11.

Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23322DOI Listing
November 2012

Referrals for suspected hematologic malignancy: a survey of primary care physicians.

Am J Hematol 2012 Jun 31;87(6):634-6. Epub 2012 Mar 31.

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23172
Publisher Site
http://dx.doi.org/10.1002/ajh.23172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358503PMC
June 2012

Update on Direct-to-Consumer Marketing in Oncology.

J Oncol Pract 2012 Mar 21;8(2):124-7. Epub 2012 Feb 21.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3457817PMC
March 2012

Sunlight exposure, vitamin D, and risk of non-Hodgkin lymphoma in the Nurses' Health Study.

Cancer Causes Control 2011 Dec 11;22(12):1731-41. Epub 2011 Oct 11.

Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-011-9849-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240999PMC
December 2011

Timeliness and quality of diagnostic care for medicare recipients with chronic lymphocytic leukemia.

Cancer 2011 Apr 8;117(7):1470-7. Epub 2010 Nov 8.

Division of Nursing Business and Health System, University of Michigan School of Nursing, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117104PMC
April 2011

The real world: CLL.

Authors:
Gregory A Abel

Blood 2011 Mar;117(13):3481-2

Dana-Farber Cancer Institute.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-01-328625DOI Listing
March 2011

Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.

Hematol Oncol 2010 Sep;28(3):133-6

Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.930DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946462PMC
September 2010

Classification of the myelodysplastic syndrome in a national registry of recently diagnosed patients.

Leuk Res 2010 Jul 6;34(7):939-41. Epub 2010 Feb 6.

Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.12.012DOI Listing
July 2010

Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

J Clin Oncol 2009 Sep 3;27(25):4182-7. Epub 2009 Aug 3.

Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St, Smith 271, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.6599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881368PMC
September 2009

Delays in referral and diagnosis for chronic hematologic malignancies: a literature review.

Leuk Lymphoma 2008 Jul;49(7):1352-9

Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802124281DOI Listing
July 2008

Chemotherapy as language: sound symbolism in cancer medication names.

Soc Sci Med 2008 Apr 4;66(8):1863-9. Epub 2008 Feb 4.

Department of Medical Oncology, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, 44 Binney Street, Smith 271, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.socscimed.2007.12.016DOI Listing
April 2008

Direct-to-consumer advertising in oncology: a content analysis of print media.

J Clin Oncol 2007 Apr;25(10):1267-71

Center for Outcomes and Policy Research, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2006.09.5968
Publisher Site
http://dx.doi.org/10.1200/JCO.2006.09.5968DOI Listing
April 2007

Direct-to-consumer advertising in oncology.

Oncologist 2006 Feb;11(2):217-26

Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, Massachusetts 02114-2617, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-2-217DOI Listing
February 2006

Effects of biochemically confirmed smoking cessation on white blood cell count.

Mayo Clin Proc 2005 Aug;80(8):1022-8

Department of Medicine , Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4065/80.8.1022DOI Listing
August 2005

Reporting enrollment in clinical trials.

Authors:
Gregory A Abel

Ann Intern Med 2002 Dec;137(12):1007-8; author reply 1007-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-137-12-200212170-00021DOI Listing
December 2002